Woman and Man
- | Country :
- Canada
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to test the potential antiviral efficacy of triple-combination therapy with Peginterferon α-2b + ribavirin + boceprevir (PRB) in patients with HCV genotype 3 who previously failed Peginterferon α + ribavirin (non-responders or relapsers).
Inclusion criteria
- Hepatitis C